Table 2

Bell-shaped isotherms for h5-HT1A receptor-mediated stimulation of [35S]GTPγ S binding to Gαi3 subunits

← Gαi3 Activation →Affinity
Ligandc1dc2a2n(pKi)
% %
5-HT9.22  ±  0.04245  ±  157.31  ±  0.0659  ±  989.21
S14671 9.65  ±  0.10258  ±  198.50  ±  0.1070  ±  14310.52
Clozapine6.74  ±  0.08267  ±  444.08  ±  0.1271  ±  2636.88
S14506 9.17  ±  0.07229  ±  178.19  ±  0.1282  ±  669.66
(+)-8-OH-DPAT9.26  ±  0.04280  ±  127.53  ±  0.0782  ±  1379.33
5-CT9.86  ±  0.06233  ±  148.27  ±  0.0592  ±  2310.10
Flesinoxan9.16  ±  0.04242  ±  67.46  ±  0.05120  ±  439.26
Ziprasidone8.49  ±  0.14255  ±  66.37  ±  0.16127  ±  1938.91
(+)-7-OH-DPAT7.02  ±  0.06267  ±  195.17  ±  0.09129  ±  1637.29
Eltoprazine8.14  ±  0.01232  ±  96.34  ±  0.02143  ±  538.19
Buspirone8.23  ±  0.07234  ±  26.45  ±  0.03153  ±  338.05
S16924 8.67  ±  0.06236  ±  136.94  ±  0.05166  ±  1638.74
(−)-8-OH-DPAT9.09  ±  0.08284  ±  207.27  ±  0.16220  ±  2039.19

Activation of Gαi3 G-protein subunits in CHO-h5-HT1A cell membranes was determined employing an antibody-capture/SPA detection technique. 5-HT and other high-efficacy agonists yielded bell-shaped isotherms. Parameters analyzed are as shown in Fig. 4. Data are expressed as mean ± s.e.m. of n independent determinations performed in duplicate. Ligands are listed according to their capacity to induce bell-shaped isotherms. For comparison, ligand affinity (pKi) is shown, as determined by competition binding with [3H]8-OH-8DPAT (Newman-Tancredi et al., 2001a,b)

    • a2, maximal inhibition of [35S]GTPγ S binding; c1, drug concentration inducing half-maximal stimulation; c2, drug concentration inducing half of the inhibitory effect; d, maximal observed stimulation relative to basal values (=100%).